Kura Oncology (KURA) investors report up to 9.7% beneficial ownership stakes

Rhea-AI Filing Summary

Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen report significant ownership stakes in Kura Oncology, Inc. common stock. Montanova Capital and Aaron Cowen each report beneficial ownership of 8,575,422 shares of common stock, representing 9.7% of the class. Averill Master Fund reports beneficial ownership of 7,805,540 shares, representing 8.8% of the class.

All of the securities reported in this Amendment No. 6 are directly owned by advisory clients of Montanova Capital, LLC, with Averill Master Fund, Ltd. being the only client that may be deemed to beneficially own more than 5% of the common stock. Each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest.

Key Figures

Montanova Capital beneficial ownership: 8,575,422 shares Montanova Capital percent of class: 9.7% Averill Master Fund beneficial ownership: 7,805,540 shares +2 more

5 metrics

Montanova Capital beneficial ownership 8,575,422 shares Beneficially owned Kura Oncology common stock; 9.7% of the class

Montanova Capital percent of class 9.7% Reported percentage of Kura Oncology common stock class

Averill Master Fund beneficial ownership 7,805,540 shares Beneficially owned Kura Oncology common stock; 8.8% of the class

Averill Master Fund percent of class 8.8% Reported percentage of Kura Oncology common stock class

Aaron Cowen beneficial ownership 8,575,422 shares Beneficially owned Kura Oncology common stock; 9.7% of the class

Key Terms

beneficial ownership, shared voting power, shared dispositive power, pecuniary interest, +1 more

5 terms

beneficial ownership financial

"Amount beneficially owned: Montanova Capital, LLC - 8,575,422"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared Voting Power 8,575,422.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 8,575,422.00"

pecuniary interest financial

"disclaims beneficial ownership...except to the extent of his, her or its pecuniary interest"

Investment Company Act of 1940 regulatory

"shareholders of an investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

What percentage of KURA does Montanova Capital, LLC report owning in this Schedule 13G/A?

Montanova Capital, LLC reports beneficial ownership of 8,575,422 shares of Kura Oncology, Inc. common stock, representing 9.7% of the class. These shares are directly owned by advisory clients of Montanova Capital, LLC.

How many KURA shares does Averill Master Fund, Ltd. report in this filing?

Averill Master Fund, Ltd. reports beneficial ownership of 7,805,540 shares of Kura Oncology, Inc. common stock, representing 8.8% of the class. These shares are directly owned as an advisory client of Montanova Capital, LLC.

What is Aaron Cowen’s reported ownership stake in Kura Oncology (KURA)?

Aaron Cowen reports beneficial ownership of 8,575,422 shares of Kura Oncology, Inc. common stock, equal to 9.7% of the class. He has shared voting and dispositive power over these shares and disclaims ownership beyond his pecuniary interest.

Who directly owns the KURA shares reported in Amendment No. 6?

All Kura Oncology, Inc. shares reported in Amendment No. 6 are directly owned by advisory clients of Montanova Capital, LLC. Among these clients, only Averill Master Fund, Ltd. may be deemed to beneficially own more than 5% of the common stock.

Do the reporting persons fully acknowledge beneficial ownership of their KURA holdings?

Each reporting person disclaims beneficial ownership of the reported Kura Oncology, Inc. securities except to the extent of their pecuniary interest. The report states it should not be deemed an admission of beneficial ownership for any purpose.

What voting and dispositive powers are reported over Kura Oncology (KURA) shares?

Montanova Capital, LLC and Aaron Cowen each report 0 shares with sole voting or dispositive power and 8,575,422 shares with shared voting and dispositive power. Averill Master Fund, Ltd. reports 7,805,540 shares with shared voting and dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:30 PM Accepted by SEC EDGAR 08/14/2026 - 04:24 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

Kura Oncology, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

50127T109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 50127T109

1

Names of Reporting Persons

Montanova Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,575,422.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,575,422.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,575,422.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.7 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 50127T109

1

Names of Reporting Persons

Averill Master Fund, Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,805,540.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,805,540.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,805,540.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.8 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP Number(s): 50127T109

1

Names of Reporting Persons

Aaron Cowen

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,575,422.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,575,422.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,575,422.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Kura Oncology, Inc.
(b)	Address of issuer's principal executive offices: 4930 Directors Place, Suite 500, San Diego, CA 92121
Item 2.
(a)	Name of person filing: Montanova Capital, LLC Averill Master Fund, Ltd. Aaron Cowen
(b)	Address or principal business office or, if none, residence: Montanova Capital, LLC 11 E 26th Street, 16th Floor New York, New York 10010 United States of America Averill Master Fund, Ltd. c/o Maples Corporate Services Limited P.O. Box 309 Ugland House Grand Cayman KY1-1104 Cayman Islands Aaron Cowen c/o Montanova Capital, LLC 11 E 26th Street, 16th Floor New York, New York 10010 United States of America
(c)	Citizenship: Montanova Capital, LLC - Delaware Averill Master Fund, Ltd. - Cayman Islands Aaron Cowen - United States
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 50127T109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Montanova Capital, LLC - 8,575,422 Averill Master Fund, Ltd. - 7,805,540 Aaron Cowen - 8,575,422
(b)	Percent of class: Montanova Capital, LLC - 9.7% Averill Master Fund, Ltd. - 8.8% Aaron Cowen - 9.7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Montanova Capital, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0
	(ii) Shared power to vote or to direct the vote: Montanova Capital, LLC - 8,575,422 Averill Master Fund, Ltd. - 7,805,540 Aaron Cowen - 8,575,422
	(iii) Sole power to dispose or to direct the disposition of: Montanova Capital, LLC - 0 Averill Master Fund, Ltd. - 0 Aaron Cowen - 0
	(iv) Shared power to dispose or to direct the disposition of: Montanova Capital, LLC - 8,575,422 Averill Master Fund, Ltd. - 7,805,540 Aaron Cowen - 8,575,422
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All of the securities reported in this Schedule 13G Amendment No. 6 are directly owned by advisory clients of Montanova Capital, LLC. None of those advisory clients, other than Averill Master Fund, Ltd., may be deemed to beneficially own more than 5% of the Common Stock, par value $0.0001 per share.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Montanova Capital, LLC

Signature:	/s/ Andrew Nathanson
Name/Title:	Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:	08/14/2026

Averill Master Fund, Ltd.

Signature:	/s/ Andrew Nathanson
Name/Title:	Andrew Nathanson, Authorized Signatory
Date:	08/14/2026

Aaron Cowen

Signature:	/s/ Aaron Cowen
Name/Title:	Aaron Cowen
Date:	08/14/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification